Financials
- Market Capitalization 588.51 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-13.61
売上高対価格比率
1.43
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2774 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.95 USD | -1.39% | +6.45% | +33.78% | +32.00% | 621.28 M USD | ||
| 2784 | TLRY Tilray Brands, Inc. - Common Stock | 4.61 USD | +0.44% | -1.50% | -0.86% | +260.16% | 627.90 M USD | ||
| 2945 | KMDA Kamada Ltd. - Ordinary Shares | 8.22 USD | -0.84% | -3.75% | +15.94% | +17.26% | 474.18 M USD | ||
| 3001 | BIOA BioAge Labs, Inc. - Common Stock | 9.35 USD | -3.11% | +0.65% | -1.58% | +23.03% | 429.14 M USD |